Vaccinating against infiltrative glioma: antigen selection, neuronal niches, and immune access

Glioma vaccines seek to direct immunity against malignant cells, including those dispersed beyond the tissue used to identify vaccine antigens. These infiltrative cells occupy neuronal, perivascular and white matter environments, where antigen expression, immune access and treatment sensitivity may differ from those in the tumor mass. In this narrative review, we examine how spatial tumor biology can guide antigen selection, vaccine platform choice, and the evaluation of antitumor immunity. We connect the pathology of diffuse invasion with evidence on neuron–glioma communication, histone mutations and glucose metabolism, tracing the steps from antigen expression to natural presentation and distinguishing systemic immunogenicity from recognition of residual cells. Histone-mutant gliomas illustrate a central difficulty: an oncogenic mutation may form a candidate antigen while shaping the tumor state in which immunity must act, yet evidence for vaccination differs across molecular entities. Studies of glucose transporter 1 similarly highlight the distinct metabolic requirements of malignant cells, myeloid cells, and effector lymphocytes. Against this background, we assess peptide, dendritic cell, nucleic acid, and viral vector approaches, with combinations designed to support immune priming or local effector function. We then propose preclinical and clinical evaluations that relate antigen coverage, presentation, and immune engagement to residual tumor control. The aim is to align vaccine design and evaluation with the biology of the infiltrative disease that remains after treatment.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-19
DOI
https://doi.org/10.3389/fimmu.2026.2005289
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Vaccinating against infiltrative glioma: antigen selection, neuronal niches, and immune access

Akira Hara, Hiroyuki Tomita
Frontiers in Immunology
Glioma Diagnosis and Treatment
article

Vaccinating against infiltrative glioma: antigen selection, neuronal niches, and immune access

Akira Hara, Hiroyuki Tomita
article en

Abstract

Glioma vaccines seek to direct immunity against malignant cells, including those dispersed beyond the tissue used to identify vaccine antigens. These infiltrative cells occupy neuronal, perivascular and white matter environments, where antigen expression, immune access and treatment sensitivity may differ from those in the tumor mass. In this narrative review, we examine how spatial tumor biology can guide antigen selection, vaccine platform choice, and the evaluation of antitumor immunity. We connect the pathology of diffuse invasion with evidence on neuron–glioma communication, histone mutations and glucose metabolism, tracing the steps from antigen expression to natural presentation and distinguishing systemic immunogenicity from recognition of residual cells. Histone-mutant gliomas illustrate a central difficulty: an oncogenic mutation may form a candidate antigen while shaping the tumor state in which immunity must act, yet evidence for vaccination differs across molecular entities. Studies of glucose transporter 1 similarly highlight the distinct metabolic requirements of malignant cells, myeloid cells, and effector lymphocytes. Against this background, we assess peptide, dendritic cell, nucleic acid, and viral vector approaches, with combinations designed to support immune priming or local effector function. We then propose preclinical and clinical evaluations that relate antigen coverage, presentation, and immune engagement to residual tumor control. The aim is to align vaccine design and evaluation with the biology of the infiltrative disease that remains after treatment.

Frontiers in ImmunologyVol. 17
Gifu University (JP), Center for One Medicine Innovative Translational Research (JP), Gifu University Institute for Advanced Study (JP)
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon